Table 1. Needle biopsy samples. Eight cases were processed histologically (H&E staining) and the presence of cancer was established in 7 of 8 samples as shown below. All samples with adenocarcinoma also contained examples of benign hyperplasia.
| Patient | Diagnosis (Biopsy) | Gleason Score |
|---|---|---|
| A1 | Adenocarcinoma + hyperplasia | 3 + 3 |
| C1 | Adenocarcinoma + hyperplasia | 3 + 3 |
| E1 | Adenocarcinoma + hyperplasia | 3 + 3 |
| F1 | Adenocarcinoma + hyperplasia | 3 + 3 |
| I1 | Hyperplasia | * |
| J1 | Adenocarcinoma + hyperplasia | 3 + 3 |
| K1 | Adenocarcinoma + hyperplasia | 3 + 3 |
| L1 | Adenocarcinoma + hyperplasia | 3 + 3 |
In each of these cases, multiple areas with cancer (minimum of 2, maximum of 5) were stained with fluorescent stem cell-specific antibodies then observed and photographed by fluorescent microscopy. Patient sample I-1 did not contain adenocarcinoma but only hyperplasia.